Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,549 INR | +1.08% | +8.58% | -1.10% |
05-14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
05-13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.10% | 2.51B | |
-16.99% | 8.67B | |
+65.60% | 4.25B | |
-9.46% | 2.47B | |
-44.11% | 2.25B | |
-7.42% | 1.91B | |
-18.68% | 1.56B | |
-41.75% | 1.19B | |
+11.31% | 1.15B | |
+14.87% | 964M |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Dr. Lal PathLabs' Consolidated Net Profit Declines in Fiscal Q4; Shares Up 3%